Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Xeris Biopharma Holdings, Inc.

NASDAQ: XERS · Life Sciences · 12 alerts · CIK 1867096

Share price
$16.70Close, Nov 16
Market cap
$3.05B
Shares outstanding
182.7MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Xeris Biopharma Holdings, Inc. filings on SEC EDGAR ↗

4:10 PM ET 10-Q
Financial Results ▶ Call

Xeris Biopharma Holdings Q3 2026 Results: Net Income $11.3M, Up 1718.0% YoY

Xeris Biopharma reported a significant increase in total revenue to $107.2 million for the third quarter of 2026, up from $74.4 million in the prior year. While the company achieved a net income of $11.3 million for the quarter, it recorded a net loss of $17.6 million for the nine-month period, largely driven by a $30.8 million loss on debt extinguishment.

Key figure
Net income $11.3M · +1718.0% YoY
7:14 AM ET 8-K
Financial Results

Xeris Biopharma Holdings Financial Results

Xeris Biopharma reported third quarter 2026 total revenue of $107.2 million, a 44% increase year-over-year, driven primarily by a 93% surge in Recorlev net revenue. The company achieved net income of $11.3 million and raised its full-year 2026 revenue guidance to a range of $395 million to $405 million.

“As a biopharmaceutical leader in endocrine and rare diseases, our strong third quarter performance puts us on a new growth curve that is accelerating our Company’s near-term outlook, and we are now on a path to reach more than $1 billion in total revenue in 2030.”

John Shannon, Chairman and Chief Executive Officer

“We now see Recorlev on a path to nearly $1 billion in annual net revenue three to four years sooner than previously expected.”

John Shannon, Chairman and Chief Executive Officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.